Xponance’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Sell |
1,308
-51
| -4% | -$15.4K | ﹤0.01% | 1035 |
|
|
2025
Q1 | $450K | Buy |
1,359
+91
| +7% | +$30.1K | ﹤0.01% | 971 |
|
|
2024
Q4 | $391K | Buy |
1,268
+113
| +10% | +$34.9K | ﹤0.01% | 1032 |
|
|
2024
Q3 | $245K | Buy |
1,155
+38
| +3% | +$8.06K | ﹤0.01% | 1155 |
|
|
2024
Q2 | $313K | Buy |
1,117
+224
| +25% | +$62.8K | ﹤0.01% | 1046 |
|
|
2024
Q1 | $238K | Buy |
893
+2
| +0.2% | +$534 | ﹤0.01% | 1132 |
|
|
2023
Q4 | $206K | Buy |
+891
| New | +$206K | ﹤0.01% | 1150 |
|
|
2023
Q1 | – | Sell |
-729
| Closed | -$212K | – | 1249 |
|
|
2022
Q4 | $212K | Buy |
+729
| New | +$212K | ﹤0.01% | 1113 |
|